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Institutional Outcomes following Total Pancreatectomy with Islet 
Autotransplantation in Children 
Stephen Sekoulopoulos and Dr. Jaimie Nathan 
Cincinnati Children’s Hospital Division of  Pediatric General and Thoracic Surgery 
Aim 
• To review our institutional outcomes following total pancreatectomy and islet 
autotransplantation for debilitating acute recurrent (ARP) and chronic pancreatitis 
(CP) in children. 
Background 
• Chronic pancreatitis is a progressive fibroinflammatory injury that can result in 
endocrine and/or exocrine insufficiency, as well as in severe pain and impaired 
quality of life. 
•The fibrotic pancreas is removed while the insulin-producing islets are isolated and 
transplanted back into the patient, usually into the liver via the portal vein.  
 
Figure 1: Total pancreatectomy 
Figure 2: Biliary and Alimentary 
Tract Reconstruction 
Figure 3: Islet 
Autotransplantation 
Methodology 
• 17 patients underwent pancreatectomy with islet autotransplantation between April 
2015 and April 2017 at Cincinnati Children’s Hospital. 
• Open, pylorus-preserving approach with accompanied splenectomy and 
gastrojejunostomy tube placement. 
• 16 total pancreatecomies and 1 subtotal pancreatectomy. 
• Islet isolation by enzymatic and mechanical digestion (Ricordi method). 
• Documented surgical complications, readmission, reoperations 90 days post-op.  
• Preoperative and postoperative opioid use was assessed, as was islet function. 
Results 
Table 1: Demographic Data 
Criteria Values (N = 17)  
Sex (female) 11 (65%) 
Age (years) 12.1 (4 - 17) 
Weight (kg) 53.6 (16.6 – 108.3) 
Height (cm) 150.2 (103 – 185.5) 
Acute Recurrent Pancreatitis (yes) 3 (18%) 
Chronic Pancreatitis (yes) 14 (82%) 
Preoperative Enteral Tube or TPN (#) 7 (41%) 
Visits for Pain 18 months prior to operation (#)  2.5 (0 – 6) 
ED visits 18 months prior to operation (#) 1.3 (0 – 6) 
Genetic mutations (yes) 14 (82%) 
PRSS1 6 (35%) 
SPINK1 5 (29%) 
CFTR 6 (35%) 
CTRC 0 (0%) 
Pancreas Divisum (yes) 8 (47%) 
Autoimmune Pancreatitis (yes)  1 (6%) 
Pancreatic Exocrine Insufficiency (yes) 8 (47%) 
Required Pre-Operative Insulin 1 (6%) 
Postop ICU Length of Stay (days) 10.4 (7 – 18) 
Total Length of Hospital Stay (days) 26.1 (19 – 36)  
Figure 4: Pre-Op and Post-Op 
Pain Management 
Figure 5: Patients Requiring 
Opioids Following TPIAT 
Type of Medication and Usage Time Following TPIAT (months) 
Table 2: Post-Operative Complications 
Complication Values (N = 17)  
Intra-Abdominal Bleeding 1 (6%) 
Upper GI Bleeding 1 (6%) 
Small Bowl Obstruction 1 (6%) 
Wound Infection 2 (12%) 
Portal Vein Thrombosis 0 (0%) 
Fluid Collection 3 (18%) 
Hypoglycemia 1 (6%) 
Table 3: Readmission and Reoperation following TPIAT 
Criteria Values (N = 17)  
Number of Patients Readmitted 6 (35%) 
Fever 1 (6%) 
Abdominal  or Other Non-Localized Pain 4 (24%) 
Enteral Tube Complications 2 (12%) 
Length of Readmission (days) 4.9 (2 - 12) 
Patients Returning to the OR 2 (12%) 
Exploratory Laparotomy  2 (12%) 
Patients Requiring an IR/Endo Procedure 6 (35%) 
Drainage of Intra-abdominal Fluid 3 (18%) 
PICC 2 (12%) 
C-Line Removal 2 (12%) 
EGD  1 (6%) 
GJ Tube Change 2 (12%) 
Therapeutic Procedure 2 (12%) 
Table 4: Islet Infusion and Insulin Use 
Criteria Values (N = 17)  
Total IEQ 330,326 (172,300 – 488,000) 
IEQ/kg 6,677 (3,992 – 14,242) 
Portal Vein Infusion 16 (94%) 
Peritoneal Cavity Infusion 1 (6%) 
Insulin Independent 4 (24%) 
Time on Insulin (months) 8 (4 – 16) 
Partial Graft Function 13 (76%) 
Conclusions 
• TPIAT is an important option in treatment of children with ARP/CP 
and is considered when maximal medical therapies and endoscopic 
approaches fail to relieve pain and to address complications. 
 
• Comprehensive multidisciplinary patient evaluation is critical to 
ensure optimal outcomes following TPIAT. 
 
• In appropriately selected children, TPIAT achieves durable pain 
relief and improves QOL with manageable glycemic control. 
